20/10/2026
A breakthrough in breast cancer detection. Made in Monaco. Applauded on the international stage.
Four years of dedication, determination and belief. And what an extraordinary moment this is!
The GALILEE study, led by Dr Florent Hugonnet and his team at Monaco’s Princess Grace Hospital (CHPG), has been recognised as one of the Top Rated Oral Presentations at EANM 2026 in Vienna!
Pink Ribbon Monaco has been proud to support this pioneering research from the very beginning.
Why is this such a big deal?
Invasive lobular breast cancer is notoriously difficult to detect. Dr Hugonnet and his team have been investigating an innovative imaging technique, with remarkable results:
100% of primary tumours detected, compared with 87% using conventional scans.
More affected lymph nodes identified. More cases of cancer spread detected.
This could mean more accurate diagnoses and better-informed treatment decisions for women facing this particularly elusive form of breast cancer.
To every person who has walked with us, donated, volunteered, sponsored an event or believed in our mission: this moment belongs to you, too.
Your support has helped make this research possible. And today, it is receiving recognition on one of Europe’s most prestigious scientific stages.
To Dr Hugonnet and his exceptional team, our warmest congratulations. What a privilege to have been part of this journey.
Think globally. Act locally. Make a difference everywhere.
Monaco EANM2026